Paper5622366
The structure of monensic acid, a new biologically active compound.
Agtarap A and 3 others. J Am Chem Soc, 1967. Cited by 152 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The structure of monensic acid, a new biologically active compound. Papers, record 5622366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/5622366
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antiprotozoal Agents | Major topic |
| Animals | |
| Antimetabolites | |
| Rats | |
| Spectrum Analysis | |
| Streptomyces |
Source PubMed
Cited by40
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 152 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,580,937 | Copper(II), a Peculiar Metal Ion for Complexation With Monensin A Ionophore. | Chemistry | 2026 | https://conductscience.org/library/papers/41580937 | PubMed |
| 40,901,411 | Insight into poultry coccidiosis: a dual focus on anticoccidial drugs and herbal plants for pharmacological and prevention strategies. | J Parasit Dis | 2025 | https://conductscience.org/library/papers/40901411 | PubMed |
| 40,715,087 | An all-in-one pipeline for the in vitro discovery and in vivo testing of Plasmodium falciparum malaria transmission blocking drugs. | Nat Commun | 2025 | https://conductscience.org/library/papers/40715087 | PubMed |
| 40,650,280 | Crystal Structure and Properties of Thallium(I) Salinomycinate. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40650280 | PubMed |
| 40,481,189 | A review of natural products as a source of next-generation drugs against apicomplexan parasites. | NPJ Antimicrob Resist | 2025 | https://conductscience.org/library/papers/40481189 | PubMed |
| 40,083,858 | Fatty acid addition strategy redirected the metabolic flux towards an ultra-high monensin productivity of Streptomyces cinnamonensis. | Synth Syst Biotechnol | 2025 | https://conductscience.org/library/papers/40083858 | PubMed |
| 38,999,058 | Heteronuclear Complexes of Hg(II) and Zn(II) with Sodium Monensinate as a Ligand. | Molecules | 2024 | https://conductscience.org/library/papers/38999058 | PubMed |
| 38,391,515 | Is the Use of Monensin Another Trojan Horse for the Spread of Antimicrobial Resistance? | Antibiotics (Basel) | 2024 | https://conductscience.org/library/papers/38391515 | PubMed |
| 37,805,629 | Triepoxide formation by a flavin-dependent monooxygenase in monensin biosynthesis. | Nat Commun | 2023 | https://conductscience.org/library/papers/37805629 | PubMed |
| 36,466,935 | Metal-Organic Framework-Based Composites for the Detection and Monitoring of Pharmaceutical Compounds in Biological and Environmental Matrices. | Water Air Soil Pollut | 2022 | https://conductscience.org/library/papers/36466935 | PubMed |
| 36,344,558 | Comparative and pangenomic analysis of the genus Streptomyces. | Sci Rep | 2022 | https://conductscience.org/library/papers/36344558 | PubMed |
| 35,854,969 | Meta-analysis of the effects of monensin on performance of beef replacement heifers and beef cows. | Transl Anim Sci | 2022 | https://conductscience.org/library/papers/35854969 | PubMed |
| 35,778,609 | Studies on Streptomyces sp. SN-593: reveromycin biosynthesis, β-carboline biomediator activating LuxR family regulator, and construction of terpenoid biosynthetic platform. | J Antibiot (Tokyo) | 2022 | https://conductscience.org/library/papers/35778609 | PubMed |
| 35,621,943 | Natural Polyether Ionophores and Their Pharmacological Profile. | Mar Drugs | 2022 | https://conductscience.org/library/papers/35621943 | PubMed |
| 35,497,416 | Factors governing the competition between group IA and IB cations for monensin A: a DFT/PCM study. | RSC Adv | 2020 | https://conductscience.org/library/papers/35497416 | PubMed |
| 34,885,968 | Influence of the Substituents on the Opening of Silylepoxy Alcohols: 5-exo-Cyclization towards Tetrahydrofurans vs. Unexpected Side Reaction Leading to Tetrahydropyrans. | Molecules | 2021 | https://conductscience.org/library/papers/34885968 | PubMed |
| 32,925,967 | The biosynthetic pathway to tetromadurin (SF2487/A80577), a polyether tetronate antibiotic. | PLoS One | 2020 | https://conductscience.org/library/papers/32925967 | PubMed |
| 31,547,063 | Actinomycete-Derived Polyketides as a Source of Antibiotics and Lead Structures for the Development of New Antimicrobial Drugs. | Antibiotics (Basel) | 2019 | https://conductscience.org/library/papers/31547063 | PubMed |
| 31,152,233 | Anticoccidial drugs of the livestock industry. | Parasitol Res | 2019 | https://conductscience.org/library/papers/31152233 | PubMed |
| 29,802,468 | Conventional and nonconventional strategies for controlling bacterial contamination in fuel ethanol fermentations. | World J Microbiol Biotechnol | 2018 | https://conductscience.org/library/papers/29802468 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/5622366
GET https://conductscience.org/api/papers/v1/5622366/cited_by?page=2